About
Small Molecules, Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalMiddle East
Team (8)
Clinical Trials (25)
View allTotal Trials
25
As Lead Sponsor
18
As Collaborator
7
Total Enrollment
2,170
By Phase
PHASE1: 7PHASE2: 10PHASE3: 1PHASE1/PHASE2: 6PHASE2/PHASE3: 1
By Status
COMPLETED: 15TERMINATED: 4RECRUITING: 2ACTIVE_NOT_RECRUITING: 2UNKNOWN: 2
Clinical Trials Pipeline25 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06442761Collaborator
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
PHASE1Recruiting
15 participants
Started: Nov 14, 2024 · Completed: Jul 31, 2028
NCT06547112Collaborator
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
PHASE1Completed
20 participants
Started: Oct 31, 2024 · Completed: Aug 19, 2025
NCT05618301Collaborator
Motixafortide and Natalizumab to Mobilize CD34+ Hematopoietic Stem Cells for Gene Therapies in Sickle Cell Disease (SCD)
PHASE1Completed
10 participants
Started: Jul 7, 2023 · Completed: Jun 24, 2025
NCT05293171Lead Sponsor
Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects
PHASE1Completed
38 participants
Started: Jun 11, 2021 · Completed: Aug 15, 2022
NCT04543071Collaborator
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
PHASE2Recruiting
10 participants
Started: Nov 9, 2020 · Completed: Aug 31, 2028
Locations (1)
Headquarters
Modi’in, Israel
Map
Loading map...